companydata.dkcompanydata.dk

BIOSTRAT BIOTECH CONSULTING ApS: Financial statements 2023

CVR: 30814622

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

BIOSTRAT BIOTECH CONSULTING ApS (CVR 30814622) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -179,724 and a net result of DKK -5,899,310 compared with DKK 8,593,417 the year before. Equity in the 2023 report amounted to DKK 65,188,076. The solvency ratio was 99.3%. The company had 1 employee in the financial year.

Gross Profit
DKK -179,724
Profit/Loss
DKK -5,899,310
Equity
DKK 65,188,076
Total Assets
DKK 65,622,045
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--180K-5.9M65.2M1
2022--274K8.6M73.1M1
2021-99K-58.8M69.5M1
2020-571K128.7M133.3M1
2019-482K344K4.9M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

BIOSTRAT BIOTECH CONSULTING ApS: The 2022 annual report is outJul 1, 2023

BIOSTRAT BIOTECH CONSULTING ApS has published its annual report for 2022. Gross profit came to DKK -273,509, and the net result was DKK 8,593,417.

About BIOSTRAT BIOTECH CONSULTING ApS

BIOSTRAT BIOTECH CONSULTING ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2007. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named NHN VENTURES ApS. The management consists of Nicolaj Højer Nielsen. The company is owned by Nicolaj Højer Nielsen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -356,755 and a net result of DKK 1,012,592 compared with DKK 18,607,304 the year before. Equity in the 2025 report amounted to DKK 26,407,972.

Source: annual report 2025, Danish Business Authority